The rising prevalence of chronic diseases is fueling growth

DUBLIN, July 21, 2022 /PRNewswire/ — The “Global Drug Delivery Devices Market Report 2022” report has been added to from offer.

The global drug delivery device market is expected to grow from $79.68 billion in 2021 for $84.1 billion in 2022 at a compound annual growth rate (CAGR) of 5.5%. The market is expected to grow to reach $100.1 billion in 2026 at a compound annual growth rate (CAGR) of 4.5%.

North America was the largest region in the drug delivery devices market in 2021. Asia Pacific was the second largest region in the drug delivery devices market. The regions covered in this report are Asia Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The increasing prevalence of chronic diseases such as cardiovascular disease, diabetes, cancer and other diseases is expected to drive the drug delivery device market. According to the World Health Organization (WHO), by 2020 chronic diseases will account for almost three-quarters of all deaths worldwide, and that 71% of deaths from ischemic heart disease (ICD), 75% of deaths from stroke, and 70% of deaths from diabetes will occur in developing countries.

Most pharmaceutical companies focus on multiple drug delivery technologies to create great benefits and better results for their marketed products. Hence, the growing prevalence of chronic diseases leads to increased consumption of drugs and therapeutic therapies, and this factor is expected to act as a driver for the growth of the drug delivery devices market.

Regulatory changes related to medical devices are expected to restrain the growth of the drug delivery devices market. Companies operating in the market are required to adapt to changes in the regulatory framework, which can limit activity on the bottom line.

Moreover, companies will have to bear the heavy cost of adapting to the evolution of the regulatory framework. In addition, sudden changes in the regulatory framework related to medical devices can lead to losses, fines, penalties on a global level. The new MDSAP will come into effect from 2020 and is adopted by regulators in the United States, Canada, Japan, Braziland Australia.


Covered markets:

1) By route of administration: Oral administration of drugs; Delivery of injectable drugs; Administration of topical medications; ocular administration of drugs; pulmonary administration of drugs; nasal administration of drugs; Transmucosal administration of drugs; Administration of implantable drugs
2) By patient care setting: Hospitals; Diagnostic centers; ambulatory surgery centres/clinics; Home care settings; Other Patient Care Parameters
3) By application: Cancer; Infectious diseases; Respiratory diseases; Diabetes; Cardiovascular illnesses; Autoimmune diseases; Central nervous system disorders; Other Apps

Main topics covered:

1. Summary

2. Features of the Drug Delivery Devices Market

3. Drug Delivery Devices Market Trends and Strategies

4. Impact of COVID-19 on Drug Delivery Devices

5. Drug Delivery Devices Market Size and Growth

6. Drug Delivery Devices Market Segmentation

7. Regional and Country Analysis of the Drug Delivery Devices Market

8. Asia Pacific Drug Delivery Devices Market

9. China Drug Delivery Devices Market

10. Drug Delivery Devices Market in India

11. Japan Drug Delivery Devices Market

12. Australia Drug Delivery Devices Market

13. Indonesia Drug Delivery Devices Market

14. South Korea Drug Delivery Devices Market

15. Western Europe Drug Delivery Devices Market

16. UK Drug Delivery Devices Market

17. Germany Drug Delivery Devices Market

18. France Drug Delivery Devices Market

19. Eastern Europe Drug Delivery Devices Market

20. Russian Drug Delivery Devices Market

21. North America Drug Delivery Devices Market

22. UNITED STATES Drug Delivery Devices Market

23. South America Drug Delivery Devices Market

24. Brazil Drug Delivery Devices Market

25. Middle East Drug Delivery Devices Market

26. Africa Drug Delivery Devices Market

27. Drug Delivery Devices Market Competitive Landscape and Company Profiles

28. Major Mergers and Acquisitions in the Drug Delivery Devices Market

29. Drug Delivery Devices Market Future Outlook and Potential Analysis

Companies cited

  • F. Hoffmann-La Roche Ltd.
  • 3M Company
  • Pfizer Inc.
  • Baxter International
  • comics.
  • Novartis AG
  • Gerresheimer S.A.
  • Johnson & Johnson Services, Inc.
  • Bayer AG
  • GlaxoSmithKline plc.
  • B. Braun Melsungen AG
  • Cipla inc.
  • Boehringer Ingelheim
  • Antares Pharma
  • Sulzer Ltd.
  • Sanofi
  • Novosanis
  • Merck & Co., Inc.
  • Island Corporation
  • OraSure Technologies, Inc.
  • Activate Injections
  • West Pharmaceutical Services, Inc.
  • SMC Ltd.
  • ViVO Smart Medical Devices Ltd.
  • medical smith
  • CareFusion Corporation
  • Abbott Laboratories
  • Nipro Corporation
  • Allergan
  • Catalent

For more information on this report, visit

Media Contact:

Research and Markets
Laura Woodsenior
[email protected]

For EST office hours, call +1-917-300-0470
For USA/CAN call toll free +1-800-526-8630
For GMT office hours call +353-1-416-8900

US Fax: 646-607-1907
Fax (outside the US): +353-1-481-1716


SOURCE Research and Markets

About Julie Gray

Check Also

Fast delivery and logistics rank high for pharmaceutical courier services in Washington DC

Swift Delivery & Logistics, the leader in truck delivery in Washington DC, tops the list …